Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients

By Strojan P.   Budihna M.   S   mid L.   Vrhovec I.   S   krk J.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1193-1197

Elsevier

Access to resources Recommend Favorite

Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells

By Moriyama Takuzou   Kataoka Hiroaki   Hamasuna Ryouichi   Yoshida Etsuo   Sameshima Tetsuro   Iseda Tsutomu   Yokogami Kiyotaka   Nakano Shinichi   Koono Masashi   Wakisaka Shinichiro  

Clinical and Experimental Metastasis, Vol. 17, Iss. 10, 1999-12 ,pp. : 873-879

Springer Publishing Company

Access to resources Recommend Favorite

Celecoxib Inhibits Urokinase-Type Plasminogen Activator (uPA) Production in MDA-MB-231 Breast Cancer Cells

By Andrews Heather   Habibi Golerah   Kucab Jill   Dunn Sandra  

Breast Cancer Research and Treatment, Vol. 94, Iss. 1, 2005-11 ,pp. : 47-52

Springer Publishing Company

Access to resources Recommend Favorite

Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface

By Gerspach Jeannette   Németh Julia   Münkel Sabine   Wajant Harald   Pfizenmaier Klaus  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1590-1600

Springer Publishing Company

Access to resources Recommend Favorite

Immunoassays of urokinase (uPA) and its type-1 inhibitor (PAI-1) in detergent extracts of breast cancer tissue

By Pedersen A.N.   Mouridsen H.T.   Tenney D.Y.   Brunner N.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 899-908

Elsevier

Access to resources Recommend Favorite